Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial.
Phase of Trial: Phase IV
Latest Information Update: 23 May 2017
At a glance
- Drugs Teriparatide (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TERA
- 28 Feb 2017 Status changed from active, no longer recruiting to completed.
- 25 Nov 2015 Planned End Date changed from 1 Aug 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.
- 25 Nov 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.